Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Syngene International Ltd. ( (IN:SYNGENE) ) just unveiled an update.
Syngene International Ltd. has notified stock exchanges that it has published its financial results for the quarter and nine months ended December 31, 2025, in the Financial Express (all-India edition) and Vijayavani (Bengaluru edition), in line with regulatory disclosure requirements. The company has also made these financial details available on its website, underscoring its compliance with listing obligations and its efforts to maintain transparency and timely communication with shareholders and market participants.
More about Syngene International Ltd.
Syngene International Ltd., part of the Biocon Group, is an India-based contract research, development and manufacturing organization (CRDMO) serving global pharmaceutical, biotechnology and other life sciences companies from its facilities in Bengaluru’s Biocon SEZ, Biocon Park.
Average Trading Volume: 47,634
Technical Sentiment Signal: Sell
Current Market Cap: 238.6B INR
See more data about SYNGENE stock on TipRanks’ Stock Analysis page.